# DESCRIPTION

## BACKGROUND OF THE INVENTION

- describe cyclin D1 regulation
- discuss ubiquitin-mediated degradation

## SUMMARY OF THE INVENTION

- introduce methods for controlling cell proliferation
- describe methods for modulating FBXW8 activity
- outline methods for screening test agents
- summarize isolated polypeptide complexes and reaction mixtures

## BRIEF DESCRIPTION OF THE DRAWINGS

- introduce patent drawings
- describe drawing figures
- illustrate phosphorylation and ubiquitination pathway
- show expression of cyclin D1 protein
- illustrate destabilization of cyclin D1 through ubiquitin-proteasome pathway
- illustrate regulation of cyclin D1 by MAPK
- illustrate ERK/MAPK as major kinase for cyclin D1 stability
- show relocalization of cyclin D1 into cytoplasm facilitates phosphorylation
- demonstrate FBXW8 ubiquitinates cyclin D1 in Thr286 phosphorylation dependent manner
- illustrate in vitro ubiquitination assays
- show regulation of cyclin D1 stability by FBXW8 through ubiquitin-proteasome pathway
- illustrate model of ubiquitination of cyclin D1 through FBXW8 complex

## DEFINITIONS

- define FBXW8 polypeptide
- define CUL1 polypeptide
- define CUL7 polypeptide
- define SKP1 polypeptide
- define MAPK polypeptide
- define cyclin D1 polypeptide
- define phosphorylated cyclin D1 polypeptide
- define interaction between polypeptides
- define various terms related to modulation and inhibition

## DETAILED DESCRIPTION OF THE INVENTION

- define scope of invention
- describe terminology and conventions

### FBXW8 Protein (F-BOX WD-40 Domain Protein 8)

- describe FBXW8 protein structure and function
- provide FBXW8 gene and protein sequences

### MAPK (Mitogen-Activated Protein Kinase)

- describe MAPK protein structure and function

### CULLIN 1 (CUL1)

- describe CUL1 protein structure and function

### Cullin 7 (CUL7)

- describe CUL7 protein structure and function

### SKP1 (S-Phase Kinase-associated Protein 1)

- describe SKP1 protein structure and function

### Cyclin D1

- describe cyclin D1 protein and its preparation methods

### Nucleic Acid Molecules, Polypeptide Production Methods, Expression Vectors, Fusion Proteins

- describe nucleic acid compositions encoding polypeptides
- describe vectors for extrachromosomal maintenance or integration into host genome
- describe transcriptional and translational regulatory nucleic acid operably linked to nucleic acid encoding protein
- describe expression vectors with selectable marker genes
- describe integrating vectors with homologous sequences for specific locus targeting
- describe viral and non-viral vectors for propagation and expression
- describe expression cassettes with transcription initiation and termination regions
- describe promoters and enhancers for regulating gene expression
- describe signal peptides for protein secretion
- describe protein production methods in various host cells

### Covalently Modified Proteins

- introduce covalently modified proteins
- define detectable tags
- describe optically-detectable labels
- describe enzyme labels
- describe radioisotopes
- describe partners of binding pairs
- describe surface substrate binding molecules
- describe indirect labeling
- describe functionalization of labels
- describe covalent attachment of tags

### Components for Polyubitquitination Assays

- introduce ubiquitination pathway components
- define ubiquitin moiety
- describe ubiquitin activating agents (E1)
- describe ubiquitin conjugating agents (E2)
- describe FBXW8-containing ubiquitin ligating agent (E3)
- introduce host cells for use in assays
- describe recombinant cells
- introduce candidate agents
- describe sources of candidate agents
- introduce components for polyubitquitination assays
- describe candidate modulators
- introduce assays to identify agents that modulate cell proliferation
- describe assay formats for identifying agents that modulate FBXW8-mediated ubiquitination of phosphorylated cyclin D1
- describe assays assessing FBXW8 binding with phosphorylated cyclin D1
- identify agents that modulate ubiquitination of phosphorylated cyclin D1 mediated by FBXW8
- describe level of cyclin D1 and/or phosphorylated cyclin D1 and/or ubiquitinated cyclin D1 in cells
- introduce assays to identify agents that modulate MAPK activity in cyclin D1 phosphorylation
- describe assays to identify agents that modulate FBXW8-mediated ubiquitination of phosphorylated cyclin D1
- conclude identification of agents that modulate cell proliferation
- define components for polyubiquitination assays
- describe assays assessing MAPK binding with cyclin D1
- describe assays assessing phosphorylated cyclin D1
- describe agents that modulate cyclin D1 phosphorylation and/or ubiquitin-mediated degradation
- describe siNAs as agents for expression-based inhibition of FBXW8, CUL1, and/or CUL7
- describe design and production of siRNAs
- describe methods for formulation and delivery of siRNAs
- provide non-limiting examples of target sites for design of siNA molecules
- describe various forms of siNA molecules
- describe properties and uses of siNA molecules
- define asymmetric duplex siNA molecule
- describe modifications for stability and efficacy
- discuss production of RNA and DNA molecules
- outline conjugates and complexes for delivery
- describe administration and formulation of agents
- discuss specific delivery methods to various tissues
- describe delivery methods
- formulate oral administration
- detail dosage levels
- administer agents in combination
- identify subjects amenable to therapy

## EXAMPLES

- introduce materials and methods
- describe cell culture and cell cycle analysis
- outline vectors, site-directed mutagenesis, and retroviral gene expression
- detail small interfering RNA (siRNA) and transformation assay
- describe immunofluorescence, immunoblotting, and immunoprecipitation analysis
- outline generation of GST-fusion proteins and in vitro kinase and ubiquitination assays

### Cyclin D1 Protein is Destabilized Specifically in S Phase in Cancer Cells

- describe cyclin D1 protein destabilization in S phase in cancer cells

### Cyclin D1 Protein is Degraded During the S Phase Through the Ubiquitin-proteasome Pathway in Cancer Cells

- describe cyclin D1 protein degradation through ubiquitin-proteasome pathway in cancer cells

### Expression of Cyclin D1 Protein in the Nucleus Decreases Through the G1-S Transition in Tumor Cells

- describe decrease of cyclin D1 protein expression in nucleus through G1-S transition in tumor cells

### Phosphorylation of Cyclin D1 Protein is Mediated by the Same Mechanism as Cyclin D1 Gene Expression, V1A the MAPK Signaling Pathway

- investigate GSK3Î² role in cyclin D1 phosphorylation

### Example 5

- identify kinase responsible for cyclin D1 Thr286 phosphorylation
- use small molecule inhibitors to determine kinase activities
- analyze phosphorylation and stability of ectopically expressed cyclin D1
- demonstrate MAPK-mediated cyclin D1 phosphorylation and destabilization
- identify D-domain in cyclin D1 protein
- perform in vitro kinase assays to determine ERK/MAPK phosphorylation of cyclin D1
- analyze half-life of ectopically expressed cyclin D1 protein following MAPK inhibition
- demonstrate MAPK regulation of cyclin D1 protein stability
- perform ubiquitination assays to determine MAPK-mediated ubiquitination of cyclin D1
- demonstrate degradation of cyclin D1 protein depends on phosphorylation at Thr286 by ERK/MAPK
- describe cyclin D1 degradation
- link degradation to MAPK phosphorylation
- identify FBXW8 as E3 ligase for cyclin D1
- show FBXW8 recognizes cyclin D1 in phosphorylation-dependent manner
- demonstrate FBXW8 ubiquitinates cyclin D1
- regulate cyclin D1 protein levels through FBXW8
- show complexes containing FBXW8 regulate cyclin D1 stability
- demonstrate FBXW8-mediated cyclin D1 degradation is required for cancer cell proliferation
- produce antibody specific to phosphorylated cyclin D1

